ERBB2 and breast carcinoma: Mechanistically, ErbB2 and v-ras-mediated downregulation of α2-integrin expression has been shown to require the Sp1 transcription factor in human breast epithelial cells [39], an event that was tied to the disruption of tissue architecture observed in breast cancer.